FORA Capital LLC Makes New $1.81 Million Investment in Doximity, Inc. $DOCS

Key Points

• FORA Capital LLC has made a new investment of $1.81 million in Doximity, Inc., acquiring approximately 31,151 shares during the first quarter.
• Institutional investors now own 87.19% of Doximity, with Vanguard Group increasing its stake by 8.8% to a total value of over $707 million.
• Doximity recently reported $0.36 earnings per share for the quarter, surpassing analyst expectations, with a revenue increase of 15.2% year-over-year.

FORA Capital LLC bought a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 31,151 shares of the company's stock, valued at approximately $1,808,000.

A number of other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company's stock valued at $707,646,000 after acquiring an additional 990,923 shares in the last quarter. Invesco Ltd. lifted its stake in shares of Doximity by 54.8% in the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company's stock valued at $114,280,000 after purchasing an additional 696,923 shares during the period. Fuller & Thaler Asset Management Inc. boosted its position in shares of Doximity by 9.5% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,730,282 shares of the company's stock valued at $100,408,000 after purchasing an additional 150,574 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Doximity by 4.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,576,455 shares of the company's stock worth $84,167,000 after purchasing an additional 63,815 shares during the period. Finally, Northern Trust Corp grew its stake in Doximity by 9.4% in the fourth quarter. Northern Trust Corp now owns 1,459,185 shares of the company's stock worth $77,906,000 after purchasing an additional 125,332 shares during the period. 87.19% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

DOCS has been the subject of several recent research reports. Canaccord Genuity Group raised their price objective on Doximity from $50.00 to $59.00 and gave the company a "hold" rating in a research report on Friday, August 8th. Robert W. Baird lowered their price target on shares of Doximity from $87.00 to $65.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. Evercore ISI raised shares of Doximity from an "in-line" rating to an "outperform" rating and boosted their price objective for the stock from $50.00 to $70.00 in a research note on Wednesday, July 9th. Bank of America upped their price objective on shares of Doximity from $55.00 to $62.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. Finally, William Blair reaffirmed an "outperform" rating on shares of Doximity in a research note on Friday, May 16th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $66.21.

Insider Transactions at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the company's stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $57.09, for a total transaction of $114,180.00. Following the transaction, the director owned 16,618 shares in the company, valued at approximately $948,721.62. This represents a 10.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy S. Cabral sold 10,000 shares of the firm's stock in a transaction dated Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the sale, the director directly owned 6,360 shares in the company, valued at approximately $381,600. The trade was a 61.12% decrease in their position. The disclosure for this sale can be found here. Insiders sold 36,000 shares of company stock worth $2,140,940 over the last quarter. 31.30% of the stock is currently owned by insiders.

Doximity Stock Performance

Shares of Doximity stock opened at $67.13 on Wednesday. The company has a 50-day simple moving average of $61.18 and a two-hundred day simple moving average of $60.45. The stock has a market capitalization of $12.57 billion, a PE ratio of 67.13, a price-to-earnings-growth ratio of 4.10 and a beta of 1.36. Doximity, Inc. has a 52-week low of $35.32 and a 52-week high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm's revenue was up 15.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities research analysts forecast that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.